[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.170.64.36. Please contact the publisher to request reinstatement.
Views 896
Citations 0
Editor's Correspondence
May 28, 2012

Fecal Transplant for Clostridium difficile

Author Affiliations

Author Affiliations: Alta Bates Summit Medical Center, Department of Medicine, University of California, San Francisco, Oakland (Dr Stollman); and Department of Medicine, University of Washington, Seattle (Dr Surawicz).

Arch Intern Med. 2012;172(10):825-826. doi:10.1001/archinternmed.2012.1055

Kassam and colleagues1 are to be congratulated on their series of patients successfully treated with “fecal transplant” for refractory or recurrent Clostridium difficile–related disease, demonstrating greater than 90% success rates—highly consistent with prior data, including ours.2

×